Inhibition of collagen II arthritis by simultaneous administration of concanavalin A and other substances with antigen emulsion.
Several pharmacological agents, some of which are known to have effects on the immune system, decrease the incidence of collagen II-induced arthritis when added to the antigen emulsion. Concanavalin A, which has been reported to exert suppressive effects on the immune system in vivo, consistently reduced the immune response to the collagen antigen. These effects were dose and time dependent. The suppressive effects of pokeweed mitogen, tilorone and carrageenan on anti-collagen II responses were somewhat variable. Suppressive activity could be observed with concanavalin A and levamisole when the drugs were injected at a site distant from the collagen emulsion. These studies indicate that local administration of drugs is an effective approach for demonstrating the activity of some agents that may alter the course of collagen II disease through an effect on the immune system.
D000818:Animals; D000941:Antigens / Q000276:immunology*; D001168:Arthritis / Q000209:etiology / Q000517:prevention & control*; D001172:Arthritis, Rheumatoid / Q000276:immunology; D003094:Collagen / Q000276:immunology*; D003208:Concanavalin A / Q000494:pharmacology*; D004655:Emulsions; D005260:Female; D006968:Hypersensitivity, Delayed; D007978:Levamisole / Q000494:pharmacology; D051381:Rats
D000941:Antigens; D004655:Emulsions; D003208:Concanavalin A; D007978:Levamisole; D003094:Collagen